TABLE 2

mRNA expression significantly suppressed by nicotine treatment in poly(I:C)-induced RAW264.7 cells (n ≥ 3/group)

Gene SymbolNamePoly(I:C)/
Control
(mean ± S.E.M.)*Nic+Poly(I:C)/
Control
(mean ± S.E.M.)*Ratio#
(R)P Value
CD14CD14 molecule0.79 ± 0.040.54 ± 0.020.680.006
EIF2AK2Eukaryotic translation initiation factor 2-alpha kinase 23.26 ± 0.142.48 ± 0.210.760.007
FADDFas (TNFRSF6)-associated via death domain0.49 ± 0.030.27 ± 0.090.550.021
IKKεInhibitor of kappaB kinase epsilon2.52 ± 0.051.74 ± 0.950.69<0.001
IL-1βInterleukin 1 beta6.02 ± 0.343.25 ± 0.850.540.006
IL-6Interleukin 657.83 ± 2.7627.54 ± 7.980.48<0.001
IRAK-4Interleukin-1 receptor-associated kinase 40.57 ± 0.030.36 ± 0.050.630.009
IRF-7Interferon regulatory factor 7146.62 ± 11.6291.1 ± 12.970.620.002
LY96Lymphocyte antigen 960.54 ± 0.020.37 ± 0.010.690.002
MDA-5Melanoma differentiation associated protein-59.79 ± 0.536.83 ± 0.040.70<0.001
PPARAPeroxisome proliferator activated receptor alpha3.01 ± 0.201.13 ± 0.230.38<0.001
RIG-IRetinoic acid-inducible gene-I21.48 ± 0.3115.33 ± 3.300.710.028
TIRAPToll-interleukin 1 receptor (TIR) domain containing adaptor protein0.71 ± 0.030.5 ± 0.090.700.029
TLR3Toll-like receptor 33.08 ± 0.161.89 ± 0.610.610.030
TNF-αTumor necrosis factor alpha1.67 ± 0.121.1 ± 0.220.660.026
  • * Expression of each gene was normalized to β-actin and then divided by PBS-control group.

  • # Ratio = [Nic + poly(I:C)]/poly(I:C).